不列颠哥伦比亚省温哥华（2022 年 9 月 22 日）——威克斯药业有限公司（“WEX”或“公司”）

Vancouver, BC (September 22, 2022) – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that a scientific poster on the Company’s lead drug candidate, Halneuron, was presented at the International Association for the Study of Pain (IASP) World Congress on Pain in Toronto, Ontario, on September 19-23, 2022.